{"id":1154,"date":"2017-09-21T14:50:15","date_gmt":"2017-09-21T14:50:15","guid":{"rendered":"https:\/\/blogs.nejm.org\/frontlines-clinical-medicine\/?p=1154"},"modified":"2017-09-21T14:50:15","modified_gmt":"2017-09-21T14:50:15","slug":"the-opioid-epidemic-one-year-later","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/frontlines-clinical-medicine\/2017\/09\/21\/the-opioid-epidemic-one-year-later\/","title":{"rendered":"The Opioid Epidemic: One Year Later"},"content":{"rendered":"
\"\"<\/a>

Harrison Reed, PA-C, practices critical care medicine in Baltimore, MD.<\/p><\/div>\n

A year ago I wrote a blog<\/a> for In Practice<\/em> and an editorial<\/a> in the Journal of the American Academy of Physician Assistants<\/em> (JAAPA<\/em>) that discussed the factors contributing to the opioid epidemic in America. If the passionate reaction to those articles is any indication, the topic stirred both intellect and emotion.<\/p>\n

Since then, the issue of opioid abuse\/overdose has not disappeared. Let\u2019s take a look at some of the recent developments.<\/p>\n

New Data Released<\/strong><\/p>\n

The Centers for Disease Control and Prevention (CDC) and other government agencies released new data<\/a> last week that shed further light on the opioid crisis. These latest data show the number of drug overdose deaths from February 2016 through February 2017. This dataset is important as it is the first to include the period of time following the CDC\u2019s updated 2016 opioid prescribing recommendations and the media frenzy that followed.<\/p>\n

Here are the trends you should know. Deaths from the three most prevalent opioid types\u2014natural\/semi-synthetic (like oxycodone\/hydrocodone), synthetic (like fentanyl), and heroin\u2014all increased over the past year despite reported drops in prescribing rates. But the largest increase in deaths was from synthetics like fentanyl (more on that later). The geographic distribution of drug overdose deaths is also uneven, with some parts of the country reporting a decline (like an 8% drop in Nebraska) while others have seen an explosion in cases (like a 63% increase in Maryland).<\/p>\n

\"\"<\/a><\/p>\n

The Rise of Fentanyl <\/strong><\/p>\n

Another storyline has emerged from both data trends and media reports<\/a>: the rise of illicit fentanyl. While the potent synthetic opioid has been a useful tool in certain medical settings for years, its illicit manufacture and abuse is one of the most significant developments in the opioid saga.<\/p>\n

Stories of fentanyl\u2019s immediate impact have filtered from some of the country\u2019s hardest-hit areas. The drug is much more potent than typical heroin and is often combined with or laced into other drugs, sometimes unbeknownst to the user. That unpredictability has resulted in body counts that, for some communities, have been treated as mass-casualty events<\/a>.<\/p>\n

A wider view of the raw numbers is startling. The one-year CDC data <\/a>mentioned above show that 14,465 people overdosed on natural and semi-synthetic opioids (like oxycodone and hydrocodone) while 15,549 people overdosed on heroin. But in the same period of time, 21,163 people died from synthetic opioids like fentanyl. Easily manufactured and highly lethal, synthetic opioids have become a frightening game-changer in the opioid epidemic.<\/p>\n

Alternative Narratives<\/strong><\/p>\n

The arrival of fentanyl and other synthetic opioids as a major player in the overdose epidemic may have also opened the door for a troubling narrative. Some in the media and medical community\u2014like the author of this editorial<\/a> published in Emergency Medicine News\u2014<\/em>point to the rise of illicit fentanyl deaths as proof that the medical community is not responsible for the epidemic.<\/p>\n

This flawed viewpoint implies a lack of obligation on the part of clinicians to find solutions to the nation\u2019s opioid dependence. It also ignores the fact that the vast majority of illicit opioid users began with a prescription drug<\/a>.<\/p>\n

You can read more analysis of this false fentanyl narrative at my website The Contralateral<\/a>.<\/em><\/p>\n

\"\"<\/a><\/p>\n

President Trump Makes a Statement<\/strong><\/p>\n

The opioid epidemic received some high level attention last month when President Trump issued a verbal statement<\/a> on the issue.<\/p>\n

\u201cThe opioid crisis is an emergency, and I\u2019m saying officially right now: it is an emergency,\u201d he said on August 10th from the steps of his New Jersey golf club.<\/p>\n

While the comment from the nation\u2019s top official brings an added spotlight, it may lack the formality needed to spur additional action. Saying something is an emergency and signing a formal declaration<\/a> of emergency are two different things. The latter would have several beneficial effects: it would make FEMA money available to states in need of assistance, allow the redeployment of Health and Human Services (HHS) personnel, and remove Medicare restrictions that act as barriers to substance abuse treatment.<\/p>\n

A formal declaration may not happen, though, if HHS Secretary Tom Price\u2019s comments are any indication.<\/p>\n

“We believe that, at this point, that the resources that we need, or the focus that we need to bring to bear to the opioid crisis can be addressed without the declaration of an emergency,\u201d he said shortly before the President\u2019s statement.<\/p>\n

The CDC Writes a Check\"\"<\/a><\/strong><\/p>\n

Despite not having a formal presidential declaration, the CDC recently awarded<\/a> an additional $28.6 million to 44 states and D.C. to help combat the opioid epidemic. The funding was part of a congressional appropriations bill signed by President Trump earlier this year and will expand several HHS programs.<\/p>\n

The money will help states bolster prescription drug monitoring programs, increase opioid risk awareness outreach, and improve surveillance and data-gathering programs.<\/p>\n

There are many more opioid-related storylines that we don\u2019t have time to cover in this blog. As new data emerge, we will need to continually reassess the impact of the epidemic and the efficacy of our interventions. If you have an important update to add, please post it in the comment section.<\/p>\n

 <\/p>\n

\"Register<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

A year ago I wrote a blog for In Practice and an editorial in the Journal of the American Academy of Physician Assistants (JAAPA) that discussed the factors contributing to the opioid epidemic in America. If the passionate reaction to those articles is any indication, the topic stirred both intellect and emotion. Since then, the […]<\/p>\n","protected":false},"author":1271,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23,35,1],"tags":[68,438,279,439],"class_list":["post-1154","post","type-post","status-publish","format-standard","hentry","category-in-the-news","category-policy","category-uncategorized","tag-emergency-medicine","tag-fentanyl","tag-opioid-abuse","tag-overdose-deaths"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/frontlines-clinical-medicine\/wp-json\/wp\/v2\/posts\/1154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/frontlines-clinical-medicine\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/frontlines-clinical-medicine\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/frontlines-clinical-medicine\/wp-json\/wp\/v2\/users\/1271"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/frontlines-clinical-medicine\/wp-json\/wp\/v2\/comments?post=1154"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/frontlines-clinical-medicine\/wp-json\/wp\/v2\/posts\/1154\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/frontlines-clinical-medicine\/wp-json\/wp\/v2\/media?parent=1154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/frontlines-clinical-medicine\/wp-json\/wp\/v2\/categories?post=1154"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/frontlines-clinical-medicine\/wp-json\/wp\/v2\/tags?post=1154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}